These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23431528)

  • 1. Orthopedic surgery is possible in hemophilic patients with inhibitors.
    Rodríguez-Merchán EC
    Am J Orthop (Belle Mead NJ); 2012 Dec; 41(12):570-4. PubMed ID: 23431528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthopaedic problems about the ankle in hemophilia.
    Rodriguez-Merchan EC
    J Foot Ankle Surg; 2012; 51(6):772-6. PubMed ID: 22785085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities.
    Rodriguez-Merchan EC; Wiedel Jd Jd; Wallny T; Caviglia H; Hvid I; Berntorp E; Rivard GE; Goddard Nj Nj; Querol F
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):109-16. PubMed ID: 14872431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and patient outcomes of surgical intervention for hemophilic arthropathy.
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2019 May; 12(5):325-333. PubMed ID: 30929534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bleeding in hemophilia patients with high-titer inhibitors.
    Leissinger CA; Konkle BA; Antunes SV
    Expert Rev Hematol; 2015 Jun; 8(3):375-82. PubMed ID: 25937074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
    Caviglia H; Candela M; Galatro G; Neme D; Moretti N; Bianco RP
    Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Articular Bleeding in Hemophilia.
    Rodriguez-Merchan EC
    Cardiovasc Hematol Disord Drug Targets; 2016; 16(1):21-24. PubMed ID: 28049407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors.
    Jiménez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Fernandez I; Hernandez-Navarro F
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S64-7. PubMed ID: 18544428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives in hemophilia treatment.
    Kessler CM
    Hematology Am Soc Hematol Educ Program; 2005; ():429-35. PubMed ID: 16304415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective orthopaedic surgery for inhibitor patients.
    Rodriguez-Merchan EC; Wiedel JD; Wallny T; Hvid I; Berntorp E; Rivard GE; Goddard NJ; Querol F; Caviglia H
    Haemophilia; 2003 Sep; 9(5):625-31. PubMed ID: 14511305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FEIBA versus NovoSeven in hemophilia patients with inhibitors.
    Franchini M; Coppola A; Tagliaferri A; Lippi G
    Semin Thromb Hemost; 2013 Oct; 39(7):772-8. PubMed ID: 24014071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
    Hvid I; Rodriguez-Merchan EC
    Haemophilia; 2002 May; 8(3):288-91. PubMed ID: 12010425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophilic arthropathy.
    Luck JV; Silva M; Rodriguez-Merchan EC; Ghalambor N; Zahiri CA; Finn RS
    J Am Acad Orthop Surg; 2004; 12(4):234-45. PubMed ID: 15473675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies.
    Teitel JM; Sholzberg M
    Blood Rev; 2013 Mar; 27(2):103-9. PubMed ID: 23452718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
    Verroust F; Moussard C; Allain JP
    Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII.
    Franchini M; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Lippi G
    Semin Thromb Hemost; 2009 Nov; 35(8):814-9. PubMed ID: 20169518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
    Ingerslev J
    Semin Thromb Hemost; 2000; 26(4):425-32. PubMed ID: 11092219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor.
    Pivalizza EG; Escobar MA
    Anesth Analg; 2008 Aug; 107(2):398-401. PubMed ID: 18633014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.